Literature DB >> 3666970

Re: Bacteremia in patients suffering from cirrhosis.

A Pahissa, J Gavaldá Santapau, L Falgueras, B Almirante, J M Martinez Vazquez.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3666970     DOI： 10.1007/bf01644130

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  7 in total

1.  Lactulose: a drug in search of a modus operandi.

Authors:  H O Conn
Journal:  Gastroenterology       Date:  1978-03       Impact factor: 22.682

2.  Effect of lactulose on ammonia production in a fecal incubation system.

Authors:  A Vince; M Killingley; O M Wrong
Journal:  Gastroenterology       Date:  1978-03       Impact factor: 22.682

3.  [Bacteremia in patients with hepatic cirrhosis. Etiopathogenic analysis and prognosis of 92 cases].

Authors:  M Javaloyas de Morlius; J Ariza Cardenal; F Gudiol Munté
Journal:  Med Clin (Barc)       Date:  1984-04-14       Impact factor: 1.725

4.  Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.

Authors:  H O Conn; C M Leevy; Z R Vlahcevic; J B Rodgers; W C Maddrey; L Seeff; L L Levy
Journal:  Gastroenterology       Date:  1977-04       Impact factor: 22.682

Review 5.  Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients.

Authors:  B E Kreger; D E Craven; P C Carling; W R McCabe
Journal:  Am J Med       Date:  1980-03       Impact factor: 4.965

6.  Risk factors for nephrotoxicity in patients treated with aminoglycosides.

Authors:  R D Moore; C R Smith; J J Lipsky; E D Mellits; P S Lietman
Journal:  Ann Intern Med       Date:  1984-03       Impact factor: 25.391

7.  Bacteremia in patients suffering from cirrhosis.

Authors:  T Almdal; P Skinhøj; H Friis
Journal:  Infection       Date:  1986 Mar-Apr       Impact factor: 3.553
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.